Wednesday, December 4, 2013

NYT > Health: Rare Cancer Treatments, Cleared by F.D.A. but Not Subject to Scrutiny

Rare Cancer Treatments, Cleared by F.D.A. but Not Subject to Scrutiny

The F.D.A. allows the sale of some devices to treat small groups of patients without requiring proof that the devices work, or any rigorous study of t...

Source: http://www.nytimes.com/2013/12/04/business/rare-cancer-treatments-cleared-by-fda-but-not-subject-to-scrutiny.html?partner=rss&emc=rss


No comments:

Post a Comment

Subscribe Now: Feed Icon